Durham, North Carolina — According to state and local development sources, AbbVie plans to invest $1.4 Billion to expand in Durham. The company is creating 734 new jobs at this facility. The company plans to complete the expansion in Durham, on or about October 1, 2028. According to the company website, AbbVie is a global biopharmaceutical company focused on creating medicines and solutions that put impact first for patients, communities, and our world. We aim to address complex health issues and enhance people’s lives through our core therapeutic areas: immunology, oncology, neuroscience, eye care, aesthetics and other areas of unmet need. AbbVie is a research-based biopharmaceutical company that develops, manufactures, and commercializes medicines for a range of serious and complex diseases. It focuses on key therapeutic areas including immunology, neuroscience, and oncology, aiming to address significant unmet medical needs. The companys operations span advanced drug discovery, clinical development, and large-scale pharmaceutical manufacturing, supported by integrated laboratory technologies and artificial intelligence.

To learn more, visit http://www.abbvie.com/

Company Contact:
AbbVie
1 Waukegan Road
North Chicago, IL60064
Phone: 847-596-8600
LinkedIn Link: https://www.linkedin.com/company/abbvie/

SOURCE: http://www.intelligence360.io
Copyright (c) 2026 SI360 Inc. All rights reserved.